Sreoshi Chatterjee 452 posts 0 comments

Diplomat Pharmacy mets out CABOMETYX treatment for Renal cell carcinoma inflicted on patients as approved by the Food and Drug administration. Formerly approved as a second-line therapy…
Read More...

BD (Becton, Dickinson and Company), global medical technology company, along with Check-Points Health B.V., affirmed that the companies sought CE Mark for a next-generation molecular…
Read More...

Labeling and detection solutions, Bio-Techne now provides reagents and kits from Vector Laboratories that doles out reliable, sensitive, and low background detection. In October, 2017,…
Read More...

Genomic and Medical research knowledge base powered by the blockchain and owned by its community, Luna DNA declared Dawn Barry as president. Barry will be held accountable for leading…
Read More...

U.S Stem Cell, Inc. claimed to be a leader in the development of proprietary stem cell therapies asserted accomplishing the target of 10,000 kit sales of proprietary Adipocell product,…
Read More...

Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...

U.S FDA approves Teva Pharmaceutical's TRISENOX i.e. Arsenic trioxide injection amalgamated with  tretinoin  in the therapy of adults diagnosed with low -risk acute promyelocytic…
Read More...

Biopharmaceutical Company, Amcure insisted on extending its team of members by further appointing  Heinz Dieter Schwer, PhD, MBA, CEO of ViraTherapeutics. Klaus Dembowsky, MD, PhD,…
Read More...

Adaptimmune Therapeutics embarks on manufacturing T-cell therapy to treat  cancer entitled SPEAR T-cells for a patient at its Navy Yard facility in Philadelphia. In addition to this…
Read More...

Celgene Corporation and Impact Biomedicinessigned and agreement that entails acquisition of Impact Biomedicines enabling development of fedratinib  for myelofibrosis and polycythemia…
Read More...